This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tetteh, K. K. A.
Right arrow Articles by Conway, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tetteh, K. K. A.
Right arrow Articles by Conway, D. J.

 Previous Article  |  Next Article 

Infection and Immunity, September 2005, p. 5928-5935, Vol. 73, No. 9
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.9.5928-5935.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Extensive Antigenic Polymorphism within the Repeat Sequence of the Plasmodium falciparum Merozoite Surface Protein 1 Block 2 Is Incorporated in a Minimal Polyvalent Immunogen{dagger}

Kevin K. A. Tetteh,1* David R. Cavanagh,2 Patrick Corran,1 Rosemary Musonda,3 Jana S. McBride,2 and David J. Conway1,4

Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel St., London WC1E 7HT, United Kingdom,1 Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, West Mains Rd., Edinburgh EH9 3JT, United Kingdom,2 Tropical Diseases Research Centre, Ndola, Zambia,3 MRC Laboratories, Fajara, P.O. Box 273, Banjul, The Gambia4

Received 18 January 2005/ Returned for modification 28 February 2005/ Accepted 13 April 2005

Polymorphism in pathogen antigens presents a complex challenge for vaccine design. A prime example is the N-terminal block 2 region of the Plasmodium falciparum merozoite surface protein 1 (MSP1), to which allele-specific antibodies have been associated with protection from malaria. In a Zambian population studied here, 49 of 91 alleles sampled were of the K1-like type (the most common of three block 2 types in all African populations), and most of these had unique sequences due to variation in tri- and hexapeptide repetitive motifs. There were significant negative correlations between allelic sequence lengths of different regions of the repeats, so the complete repeat sequence had less length variation than its component parts, suggesting a constraint on overall length. Diverse epitopes recognized by three murine monoclonal antibodies and 24 individual human sera were then mapped by using a comprehensive panel of synthetic peptides, revealing epitopes in all regions of the repeats. To incorporate these different epitopes in a single molecule, a composite sequence of minimal overall length (78 amino acids) was then designed and expressed as a recombinant antigen. More human immune sera reacted with this "K1-like Super Repeat" antigen than with proteins consisting of single natural allelic sequences, and immunization of mice elicited antibodies that recognized a range of five cultured parasite lines with diverse K1-like MSP1 block 2 repeat sequences. Thus, complex allelic polymorphism was deconstructed and a minimal composite polyvalent antigen was engineered, delivering a designed candidate sequence for inclusion in a malaria vaccine.

* Corresponding author. Mailing address: Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel St., London WC1E 7HT, United Kingdom. Phone: 20-7927-2416. Fax: 20-7636-8739. E-mail: kevin.tetteh{at}lshtm.ac.uk.

{dagger} Supplemental material for this article may be found at http://iai.asm.org/.

Editor: W. A. Petri, Jr.

Infection and Immunity, September 2005, p. 5928-5935, Vol. 73, No. 9
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.9.5928-5935.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Gray, J. C., Corran, P. H., Mangia, E., Gaunt, M. W., Li, Q., Tetteh, K. K.A., Polley, S. D., Conway, D. J., Holder, A. A., Bacarese-Hamilton, T., Riley, E. M., Crisanti, A. (2007). Profiling the Antibody Immune Response against Blood Stage Malaria Vaccine Candidates. Clin. Chem. 53: 1244-1253 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»